Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy.
Amano
Koichi
K
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D009894:Opportunistic Infections / Q000209:etiology; D016720:Pneumocystis Infections / Q000209:etiology; D045363:Pneumocystis carinii / Q000472:pathogenicity; D012141:Respiratory Tract Infections / Q000382:microbiology*; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab